WASHINGTON, July 14, 2016 /PRNewswire/ -- Danaher
Corporation (NYSE: DHR) announced today that its Board of Directors
has appointed Robert J. Hugin to
Danaher's Board of Directors. The Board also appointed Mr. Hugin to
the Compensation Committee of Danaher's Board.
Mr. Hugin serves as the Executive Chairman of the Board of
Directors of Celgene Corporation (NASDAQ: CELG). Since
joining Celgene in 1999, he has served in a series of progressively
more responsible leadership positions including serving as Chief
Executive Officer from June 2010
until March 2016. Prior to joining Celgene, Mr. Hugin served
as a Managing Director at J.P. Morgan & Co. Inc., which he
joined in 1985. From 1976 to 1983, Mr. Hugin served as a
United States Marine Corps
infantry officer.
Steven M. Rales, Chairman of the Board of Danaher Corporation,
said, "We are extremely pleased to welcome Bob to our Board of
Directors. With his extensive leadership experience in the
biopharmaceutical market, we believe he will be an outstanding
asset to our Board and to Danaher."
ABOUT DANAHER
Danaher is a global science and
technology innovator committed to helping its customers solve
complex challenges and improving quality of life around the world.
Its family of world class brands have leadership positions in some
of the most demanding and attractive industries, including health
care, environmental and industrial. With more than 20 operating
companies, Danaher's globally diverse team of 59,000 associates is
united by a common culture and operating system, the Danaher
Business System. For more information please visit
www.danaher.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/danaher-announces-appointment-of-robert-j-hugin-to-danaher-board-300298937.html
SOURCE Danaher Corporation